Oncogenic Ras (H-Ras G12V) inhibits skeletal myogenesis through multiple signaling pathways. Previously, we demonstrated that the major downstream eectors of Ras (i.e., MEK/MAPK, RalGDS and Rac/Rho) play a minor, if any, role in the dierentiation-defective phenotype of Ras myoblasts. Recently, NFkB, another Ras signaling target, has been shown to inhibit myogenesis presumably by stimulating cyclin D1 accumulation and cell cycle progression. In this study, we address the involvement of NFkB activation in the Ras-induced inhibition of myogenesis. Using H-Ras G12V and three G12V eector-loop variants, we detect high levels of NFkB transcriptional activity in C3H10T1/2-MyoD cells treated with dierentiation medium. Myogenesis is blocked by all Ras proteins tested, yet only in the case of H-Ras G12V are cyclin D1 levels increased and cell cycle progression maintained. Expression of IkBa SR, an inhibitor of NFkB, does not reverse the dierentiation-defective phenotype of Ras expressing cultures, but does induce dierentiation in cultures treated with tumor necrosis factor (TNFa) or in cultures expressing the RelA/p65 subunit of NFkB. These data con®rm that NFkB is a target of Ras and suggest that the cellular actions of NFkB require additional signals that are discriminated by the Ras eector-loop variants. Results with IkBa SR convincingly demonstrate that H-Ras G12V does not rely on NFkB activity to block myogenesis, an observation that continues to implicate another unidenti®ed signaling pathway(s) in the inhibition of skeletal myogenesis by Ras. Oncogene (2001) 20, 1276 ± 1286 
Introduction
Ras proteins are membrane-localized, small molecular weight GTPases that play a pivotal role in cellular proliferation, transformation and dierentiation. Ras GTPases are the nodal point in an intracellular signaling network that relays key growth signals from receptor protein tyrosine kinases to downstream signaling intermediates. Ras function is essential for cellular proliferation and progression through the G1 phase of the cell cycle (Feramisco et al., 1984; Mulcahy et al., 1985; Dobrowolski et al., 1994; Aktas et al., 1997) . A number of studies also have shown that Ras activity exerts dramatic and varied eects on developmental decisions. For example, signaling through Ras and its downstream eectors is essential for neurite outgrowth in PC12 cells (Bar-Sagi and Feramisco, 1985; Robbins et al., 1992; Thomas et al., 1992; Wood et al., 1992) , while Ras activation blocks both the biochemical and morphological dierentiation of skeletal muscle (Olson et al., 1987; Gossett et al., 1988; Konieczny et al., 1989; Lassar et al., 1989; Kong et al., 1995) . The inhibition of myogenesis by oncogenic Ras has proven to be a particularly useful model for investigating the Ras eector pathways in muscle that in¯uence individual cell growth, dierentiation and transformation functions (Ramocki et al., , 1998 Weyman et al., 1997) .
Previous studies have demonstrated that oncogenic Ras (H-Ras G12V) and a panel of transformationde®cient Ras eector-loop variants inhibit MyoDinduced myogenesis in C3H10T1/2 (10T1/2) cells (Ramocki et al., , 1998 . Ras eector-loop variants are useful for examining Ras signaling pathways since each interacts with a distinct set of downstream Ras eector molecules. The H-Ras G12V, T35S variant retains Raf-1 binding and thus selectively activates the MEK/MAPK pathway (White et al., 1995) . H-Ras G12V,E37G does not bind Raf-1 and signals predominantly through the guanine nucleotide exchange activity of RalGDS Miller et al., 1997) . Ras G12V, Y40C leads to the activation of the Rac/Rho GTPases and PI3 kinase (Joneson et al., 1996; Rodriguez-Viciana et al., 1997) . Interestingly, each of these three Ras eector-loop variants inhibits myogenesis in a manner that is independent of their characterized downstream signaling targets. This strongly suggests that other Ras eectors and/or pathways not discriminated by these variants are critical to the Ras-induced inhibition of skeletal myogenesis.
One pathway that has not been examined with regard to the Ras-mediated inhibition of myogenesis is the NFkB pathway. NFkB belongs to the Rel family of transcription factors and regulates genes involved in several cellular functions, including immune and in¯ammatory responses, apoptosis and cell growth (reviewed in Pahl, 1999) . In vertebrates, the Rel/NFkB family consists of ®ve proteins ± RelA/p65, RelB, c-Rel, p50 (NF-kB1) and p52 (NF-kB2) ± which form homodimers or heterodimers and bind to speci®c DNA target sites to regulate gene expression (reviewed in Baldwin, 1996; May and Ghosh, 1997) . Dierent combinations of NFkB subunits vary in their DNAbinding and activation potentials and only RelA, RelB and c-Rel possess transcription activation domains (reviewed in Verma et al., 1995) . The best characterized form of NFkB is a heterodimer composed of the RelA/ p65 and p50 subunits. In most unstimulated cells, this heterodimer is present as an inactive, cytoplasmic complex bound by a member of an inhibitory protein family referred to as IkB (reviewed in Verma et al., 1995) . Upon exposure of cells to a variety of stimuli, including mitogens and growth factors, IkB becomes phosphorylated on two serine residues located within the amino terminus. In its phosphorylated state, IkB is targeted for ubiquitin-dependent degradation, releasing NFkB which translocates to the nucleus to impact gene expression (reviewed in Baldwin, 1996; Karin, 1999) .
Although the role of the NFkB transcription complex as a regulator of genes involved in immunological responses is well-de®ned (reviewed in Pahl, 1999) , recent studies have focused on the role of NFkB in promoting cell growth. Cells in which NFkB activation is blocked suer a delay in progression through the G1 phase of the cell cycle (Bargou et al., 1997; Grumont et al., 1998; Guttridge et al., 1999; Hinz et al., 1999) . This cell cycle defect, in part, could be the result of the inecient accumulation of cyclin D1 since the cyclin D1 promoter contains consensus NFkB binding sites that are transcriptionally responsive following the stimulation of NFkB activity in cells (Guttridge et al., 1999; Hinz et al., 1999) .
NFkB serves as an important downstream target for Ras-activated signal transduction pathways. NFkB is required for Ras-mediated cellular transformation (Finco et al., 1997; Jo et al., 2000) and is thought to play a role in protecting Ras-transformed cells from undergoing apoptosis (Mayo et al., 1997) . Ras activation results not only in the nuclear accumulation of NFkB, but also in the stimulation of the transcription function ascribed to the RelA/p65 subunit of the NFkB heterodimer (Finco et al., 1997; Norris and Baldwin, 1999) . Furthermore, Ras signaling, like NFkB activation, results in increased cyclin D1 transcription and protein levels (Albanese et al., 1995; Aktas et al., 1997; Gille and Downward, 1999; Hitomi and Stacey, 1999) . Recently, Guttridge et al. (1999) showed that constitutive activation of NFkB is a potent inhibitor of skeletal muscle dierentiation, presumably by preventing proper cell cycle arrest in dierentiation-induced cultures. This model was consistent with previous reports demonstrating that ectopic expression of cyclin D1 blocks myogenesis in a cyclindependent kinase (Cdk)-dependent manner (Rao et al., 1994; Skapek et al., 1995; Zhang et al., 1999) . Based on these observations, it is logical to conclude that oncogenic Ras utilizes the activities of NFkB to stimulate G1 phase cell cycle progression and thus to block the terminal dierentiation of skeletal muscle cells.
In this study, we have tested the role of NFkB in the Ras-induced inhibition of myogenesis. Our results demonstrate that while oncogenic Ras and each of the Ras eector-loop variants described above eectively activate NFkB-dependent transcriptional activity in MyoD-induced 10T1/2 cells, only oncogenic Ras leads to increased cyclin D1 protein levels and continued cell cycle progression. Additionally, we demonstrate that the inhibition of dierentiation by all Ras constructs tested is not relieved by the overexpression of IkBa SR, a potent inhibitor of NFkB activity. This is in stark contrast to the IkBa SR-mediated reversal of the block in myogenic dierentiation induced by TNFa treatment or by forced expression of the RelA/p65 subunit of NFkB. These data rule out a major role for NFkB in the Rasmediated inhibition of myogenesis and continue to support the existence of a yet to be characterized pathway(s) that mediates the inhibitory eects of Ras activation on skeletal muscle dierentiation.
Results
H-Ras G12V and G12V effector-loop variants stimulate NFkB-mediated transcription in differentiation-induced 10T1/2 cells H-Ras G12V and G12V eector-loop variants enhance NFkB transcriptional activity in proliferating cells (Finco et al., 1997) , but the ability of these proteins to enhance NFkB activity in cells maintained under low growth, dierentiation-inducing conditions has not been examined. Using a luciferase reporter gene containing three tandem kB sites (36kB-Luc) as a read-out for NFkB activation, 10T1/2 cells were transfected with an expression vector for MyoD and vectors encoding one of the following proteins: oncogenic H-Ras (Ras G12V); Ras G12V, T35S; Ras G12V, E37G; Ras G12V, Y40C or the RelA/p65 subunit of NFkB. Cultures were treated with dierentiation-inducing medium (DM) and luciferase activities measured as described in Materials and methods. Cells co-expressing MyoD and Ras G12V or MyoD and each of the Ras eector-loop mutants exhibit a 2 ± 3-fold increase in 36kB-Luc reporter activity when compared to the vector only control (Figure 1) . A similar level of 36kB-Luc expression is obtained with the transcriptionally active p65 subunit of NFkB. Activation of the 36kB-Luc reporter in this experiment is a direct result of stimulating endogenous NFkB activity, since co-expression of a constitutively active IkBa protein (IkBa SR) eectively blocks luciferase accumulation in all groups (Figure 1 ). IkBa SR expression has no eect on the transcriptional activity of control reporter genes assayed in parallel (data not shown), con®rming that IkBa SR is not functioning as a general repressor of transcription in this model system. These data suggest that for MyoD expressing 10T1/2 cells maintained in DM, Ras G12V and each of the Ras eector-loop mutants tested enhance NFkBmediated transcription.
H-Ras G12V proteins and NFkB inhibit myogenesis in 10T1/2-MyoD-ER cells Recently, it has been reported that NFkB activation inhibits myogenesis (Guttridge et al., 1999) . C2C12 myoblasts treated with TNFa, an activator of NFkB, are blocked from dierentiating and forced expression of the p65/RelA subunit of NFkB in 10T1/2 cells inhibits the activation of muscle-speci®c reporter genes by MyoD (Guttridge et al., 1999) . To extend these observations, we compared the ability of NFkB and Ras G12V to inhibit myogenesis in a 10T1/2-MyoD inducible cell line (10T1/2-MyoD-ER) (Hollenberg et al., 1993) . 10T1/2-MyoD-ER cells commit to terminal dierentiation only when the MyoD-estrogen receptor (ER) fusion protein is activated by the addition of bestradiol to DM. As shown in Figure 2 , 98% of the 10T1/2-MyoD-ER cells terminally dierentiate in the presence of b-estradiol as assayed by the expression of troponin T. Following transfection with expression vectors for Ras G12V or the G12V eector-loop variants T35S and E37G, the myogenic program is severely compromised. Interestingly, expression of Ras G12V, Y40C also inhibits myogenesis in induced MyoD-ER cells but, in this instance, the block in dierentiation is not as complete as with the other Ras forms. As expected, treatment of 10T/2-MyoD-ER cells with TNFa also proves to be a potent inhibitor of terminal dierentiation (Figure 2 ). We established that TNFa functions through NFkB activation in these cells by measuring the stimulation of 36kB-Luc reporter gene activity by TNFa and observing the restoration of myogenesis in TNFa-treated cultures following expression of IkB SR (data not shown). The data in Figures 1 and 2 provide strong evidence of a direct link between Ras and NFkB activities in 10T1/2-MyoD expressing cells and suggest that NFkB could function as the downstream eector mediating the inhibition of myogenesis by Ras.
Effects of Ras and NFkB activation on cell cycle progression in 10T1/2-MyoD-ER cells
An early event in myogenic dierentiation is the irreversible withdrawal of myoblasts from the cell cycle. As a result, one mechanism proposed for the block of myogenesis by constitutive activation of NFkB is the induction of cell cycle progression (Guttridge et al., 1999) . Considering the role of Ras signaling in cellular proliferation and transformation, it is possible that Ras activation inhibits muscle dierentiation via this same mechanism. To test this possibility, we quanti®ed the percentage of cells that continue to synthesize DNA (i.e., proliferate) in DM/bestradiol-treated 10T1/2-MyoD-ER myoblasts blocked from dierentiating by the expression of H-Ras G12V or the Ras eector-loop variants or by exposure to TNFa (Figure 3 ). Vector transfected 10T1/2-MyoD-ER cells grown in the absence of inducer continue to proliferate as revealed by the high percentage of BrdU positive cells in the culture. Induction of MyoD activity with b-estradiol rapidly results in cell cycle arrest since only 5% of the cells remain BrdU positive. Interestingly, cells treated with b-estradiol and expressing Ras G12V exhibit an increase in the number of cycling cells relative to the vector control, suggesting that Ras G12V expression supports a signi®cant level of cell proliferation in DM. Similarly, 10T1/2-MyoD-ER cells in DM supplemented with b-estradiol and TNFa proliferate. In striking contrast to the behavior of the H-Ras G12V transfected cells, cells transfected with the Ras eector-loop variants (Ras G12V, T35S; Ras G12V, E37G; Ras G12V, Y40C) arrest growth in DM plus b-estradiol, even though the cultures do not dierentiate (see Figure 2) . We conclude that the inhibition of myogenesis by the Ras eector-loop variants must occur through a pathway(s) that does not impinge on signals directing proper cell cycle arrest in DM.
To investigate one potential molecular correlate of the cell cycle progression induced by H-Ras G12V and TNFa, we utilized cyclin D1 antisera to detect cyclin D1 accumulation in 10T1/2-MyoD-ER cells induced to dierentiate with DM and b-estradiol. In a previous study, Guttridge et al. (1999) described accumulation of cyclin D1 protein accompanying the treatment of Figure 1 H-Ras G12V proteins induce NFkB transcriptional activity. 10T1/2 cells were transfected with 1 mg of 36kB-Luc, 0.25 mg of pEM-MyoD and 0.5 mg of pDCR vector (control), Ras G12V, Ras G12V,T35S, Ras G12V,E37G, Ras G12V,Y40C, RelA/p65 or 1 mg of IkB SR as described in Materials and methods. Twenty-four hours after transfection, the culture medium was switched to DM for 24 h. Cell extracts were prepared, normalized for protein content and assayed for luciferase activity as described previously . Luciferase activity is expressed relative to the control group which is set at 100. Error bars indicate the standard error of the mean dierentiating myoblasts with TNFa. Whether a similar induction of cyclin D1 accompanies Ras activation in myoblasts has not been examined. As shown in Figure 4 , approximately 50% of vector transfected control cells maintained in the absence of b-estradiol stain positive for cyclin D1. Following induction of dierentiation, the number of cyclin D1 positive cells in these cultures drops to 10%, consistent with previous reports showing that cyclin D1 mRNA and protein decline as myoblasts arrest in early G1 (Rao et al., 1994; Skapek et al., 1995) . Interestingly, 10T1/2-MyoD-ER cells exposed to b-estradiol and expressing the Ras G12V protein exhibit a sevenfold increase in cyclin D1 positive cells when compared to the control b-estradiol group, suggesting that Ras G12V supports G1 phase progression in DM by upregulating cyclin D1 protein levels. When cells transfected with each of the Ras eector-loop variants were examined, however, the number of cyclin D1 positive cells was not signi®cantly dierent than the number in the b-estradiol control. Thus, the data in Figures 3 and 4 indicate that the Ras eector-loop variants block myogenesis in DM-treated 10T1/2-MyoD-ER cells by a mechanism that does not involve cyclin D1 accumulation or continued G1-S phase progression.
Figure 2 H-Ras G12V proteins inhibit myogenesis. 10T1/2-MyoD-ER cells were transiently transfected with 2 mg of pDCR vector (control), Ras G12V, Ras G12V,T35S, Ras G12V,E37G or Ras G12V,Y40C. Twenty-four hours following transfection, the culture medium was switched to DM plus b-estradiol. Where indicated, 20 ng/ml TNFa was added at the time of addition of DM and again 12 h afterwards. Forty-eight hours following induction, the cells were ®xed and immunostained for troponin T (TnT) and H-Ras expression as described in Materials and methods. (a) The number of H-Ras-positive cells that also express TnT was determined for each experimental group. The experiment was performed multiple times and the percentages averaged from 10 independent microscope ®elds per experiment. Error bars represent the standard error of the mean. 
IkBa expression does not reverse Ras-induced inhibition of skeletal muscle differentiation
Our results indicate that Ras eector-loop variants are likely to impact a set of cellular targets that is distinct from the set activated by NFkB to block myogenesis. This in turn suggests that TNFa-induced activation of NFkB is qualitatively dierent from Ras-induced activation of NFkB in this model system, even though other studies have reported that Ras activation mediates or enhances the eects of TNFa signaling in some cell types (Trent et al., 1996; Anrather et al., 1999) . To address the question of whether NFkB serves as an obligate target of Ras signaling to inhibit myogenesis, we began by examining if TNFa-induced activation of NFkB in this system relies on endogenous Ras p21 function. For these experiments we used Ras N17, a dominant-negative form of H-Ras, that competitively inhibits the guanine nucleotide exchange required to activate endogenous Ras p21 (Feig and Cooper, 1988) . The biological activity of the Ras N17 protein in 10T1/2 cells ®rst was established using epidermal growth factor (EGF)-stimulated, Rasmediated activation of Gal4-Elk1 as a readout. As shown in Figure 5a , the (Gal4) 5 -Luc reporter gene is expressed to high levels in control cells transfected with Gal4-Elk1 and stimulated with EGF, while in cells transfected with Ras N17 and treated with EGF, luciferase activity is repressed by 60%. 10T1/2 cells then were transfected with MyoD and 36kB-Luc in the presence or absence of Ras N17 and luciferase activities measured after exposure to DM containing or lacking TNFa. As shown in Figure 5b , TNFa stimulates a high level of 36kB-Luc expression which is not reduced in the presence of Ras N17. In addition, Ras N17 does not reverse the TNFa-induced inhibition of myogenesis as measured by the MyoD-mediated activation of TnI-Luc gene expression (Figure 5c ) and the formation of multinucleate myo®bers in the culture Figure 3 Ras eector-loop variants do not compromise cell cycle arrest in dierentiation-induced cultures. 10T1/2-MyoD-ER cells were transiently transfected with 2 mg of pDCR vector (control); Ras G12V, Ras G12V,T35S, Ras G12V,E37G or Ras G12V,Y40C. Twenty-four hours after transfection the culture medium was switched to DM plus b-estradiol. Where indicated, 20 ng/ml TNFa was added with the DM and every 12 h afterwards. Thirty hours following induction, 10 mM 5-bromo-2'-deoxy-uridine (BrdU) was added to the dierentiation medium and 18 h later, the cells were ®xed and immunostained for BrdU incorporation into DNA as described in Materials and methods. The number of H-Ras-positive cells that were also BrDU positive was determined for each experimental group. The experiment was performed multiple times and the percentages averaged from 10 independent microscope ®elds per experiment. Error bars represent the standard error of the mean Figure 4 H-Ras G12V, but not the Ras eector-loop variants, cause increased cyclin D1 protein expression in DM. 10T1/2-MyoD-ER cells were transiently transfected with the indicated plasmid DNA as in Figure 3 . Twenty-four hours following transfection, the culture medium was switched to DM plus bestradiol. Forty-eight hours following induction of dierentiation, the cells were ®xed and immunostained for cyclin D1 and H-Ras expression as described in Materials and methods. (data not shown). This suggests that the eects of TNFa in stimulating NFkB activation and the inhibition of skeletal muscle dierentiation in this model system do not rely on the activation of endogenous Ras p21.
To establish if the Ras-initiated inhibition of myogenesis relies on the NFkB pathway, we employed the constitutive NFkB inhibitory protein, IkBa SR, to prevent activation of NFkB in response to Ras signaling (see Figure 1) . As a control, we duplicated previously reported experiments in which IkBa SR was used to revert the non-myogenic phenotype of 10T1/2 myoblasts transfected with the RelA/p65 subunit of NFkB (Guttridge et al., 1999) . 10T1/2 cells were cotransfected with the muscle-speci®c TnI-Luc reporter gene, a vector expressing MyoD and vectors for H-Ras G12V, each of the Ras eector-loop variants, p65 or, where indicated, IkBa SR. Expression of each introduced protein was con®rmed by Western blot analysis ( Figure 6b and data not shown). Following induction of dierentiation, relative TnI-Luc activity was measured for each group, setting the MyoD-mediated activation of TnI-Luc to 100 (Figure 6a ). Cells expressing H-Ras G12V, each of the eector-loop variants or RelA/p65 did not permit induction of TnILuc expression by MyoD. Introduction of the IkBa SR expression vector in the MyoD control group generates almost a twofold increase in TnI-Luc expression which is consistent with the report showing a positive in¯uence of NFkB inhibition on myogenesis (Guttridge et al., 1999) . While IkB SR eciently reverses the inhibition of TnI-Luc expression by NFkB, IkBa SR is unable to restore expression of this muscle-speci®c gene in groups expressing any of the Ras proteins.
To insure that the inability of the IkB SR protein to restore TnI-Luc expression in Ras-inhibited cultures is an accurate re¯ection of other aspects of myogenic dierentiation, the transfection was repeated and the dierentiation-induced cultures ®xed and immunostained for myosin heavy chain protein as described in Materials and methods. Myo®ber formation was scored by visual inspection (Figure 6c and d) and reveals the presence of fully dierentiated, myosinpositive ®bers in the IkB SR/RelA group, but not in the IkB SR/Ras G12V group. We conclude from these data that while Ras activates NFkB and NFkB activation in response to other stimuli (e.g. TNFa) inhibits skeletal muscle dierentiation, NFkB is not essential in the signaling pathway through which Ras blocks the biochemical and morphological dierentiation of 10T1/2-MyoD myoblasts. Figure 5 TNFa-induced activation of NFkB in 10T1/2 cells is Ras-independent and Ras inhibition of myogenesis does not rely on NFkB. (a) 10T1/2 cells were transiently transfected with 1 mg of (Gal4) 5 -Luc, 0.5 mg of Gal4-Elk1 and 0.5 mg of Ras N17 in growth medium. Twenty-four hours after transfection, the culture medium was switched to DMEM-H. Twenty-four hours later, EGF was added (to a ®nal concentration of 100 ng/ml) and the cells stimulated for 3 h. Cell extracts were prepared, normalized for protein content and assayed for luciferase activity as described previously . (b) 10T1/2 cells were transiently transfected with 1 mg of 36kB-Luc, 0.25 mg of MyoD and 0.5 mg of pDCR vector or pSVX Ras N17. Twenty-four hours following transfection the culture medium was switched to DM and TNFa (20 ng/ml) was added to the indicated groups. TNFa was added again and at 12 and 24 h following induction, cell extracts were prepared, normalized for protein content and assayed for luciferase activity. (c) 10T1/2 cells were transiently transfected with 1 mg of TnI-Luc, 0.25 mg of MyoD and 0.5 mg of pDCR vector or pSVX Ras N17. Cells were treated the same way as described in (b) and luciferase activity for each experimental group was expressed relative to the control which was set at 100. Error bars indicate the standard error of the mean
Discussion
The dierentiation of skeletal muscle precursor cells in culture is marked by the transcriptional activation of muscle-speci®c genes and the morphological dierentiation of myoblasts into multinucleate myotubes. Thus, myogenesis is an attractive model in which to dissect the signaling pathways that regulate various aspects of the process and serve to enhance, or to inhibit, this developmental progression. We have used skeletal muscle dierentiation to show that the signaling pathways activated by an oncogenic Ras protein inhibit 
D.
Figure 6 IkBa SR expression does not reverse the inhibitory eect of Ras on myogenesis. (a) 10T1/2 cells were transfected with 1 mg of TnI-Luc, 0.25 mg of MyoD and 0.5 mg of pDCR vector (control), Ras G12V, Ras G12V,T35S; Ras G12V,E37G, Ras G12V,Y40C or p65/RelA. Where indicated (black bars), cells also received 1 mg of IkBa SR. Twenty-four hours following transfection the culture medium was switched to DM for 24 h. Cell extracts were prepared, normalized for protein content and assayed for luciferase activity as described previously . Luciferase activity is expressed relative to the control which was set at 100. Error bars indicate the standard error of the mean. (b) 10T1/2 cells were transiently transfected with the indicated plasmids and treated with DM as in (a). Cell extracts were prepared and analysed by Western blot hybridization as described in Materials and methods. Anti-HA antiserum was used to detect H-Ras and anti-Flag antiserum was used to detect the IkBa SR and RelA/p65 proteins. (c) 10T1/2 cells were transiently transfected with 2 mg of MyoD and 3 mg of pDCR vector (control), Ras G12V or p65/RelA DNA. Where indicated, 6 mg of IkB SR were added to inhibit NFkB activity. After 48 h in DM, the cells were ®xed, immunostained for myosin heavy chain protein and scored for myo®ber formation as described in Materials and methods. The values presented are the average myo®ber formation of each group expressed relative to the MyoD control group, which is set to 100. Error bars indicate the standard error of the mean of the ®ve counts used to obtain the average for each experimental group. (d) Representative photographs of the immunostained cultures scored for myo®ber formation in (c) both the biochemical and the morphological dierentiation of the cells (Konieczny et al., 1989; Lassar et al., 1989; Vaidya et al., 1991) . Transformationdefective, Ras eector-loop variants, each of which signals predominantly through a subset of Ras eectors, also block myogenesis (Ramocki et al., , 1998 . This inhibition has been demonstrated in transient gene expression assays (Ramocki et al., , 1998 , in myoblast cell lines stably expressing Ras proteins (M Ramocki and E Taparowsky, unpublished data) and, in this study, using the 10T1/2-MyoD-ER cell line. The simplest interpretation of these data is that each of the Ras eector pathways is sucient to block myogenesis. However, using constitutively active or dominant-negative signaling molecules and speci®c chemical inhibitors of Ras eector pathways, we and others have shown that none of these Ras pathways, alone or in combination, duplicate the eects of Ras in this system (Kaliman et al., 1996; Bennett and Tonks, 1997; Pinset et al., 1997; Weyman et al., 1997; Ramocki et al., 1998; Takano et al., 1998; Dorman and Johnson, 1999) . For example, while constitutive activation of MAP kinase in the absence of Ras G12V eectively blocks the early stages of muscle dierentiation (Bennett and Tonks, 1997; Ramocki et al., 1997; Dorman and Johnson, 1999) , preventing MAP kinase activation in cells expressing Ras G12V or the T35S eector domain variant does not reverse the nonmyogenic phenotype of the cells Weyman et al., 1997) . Similarly, whereas oncogenic Ras is known to activate PI3 kinase and the Rho GTPases in cells (Rodriguez-Viciana et al., 1994; Prendergast et al., 1995) , exposure of myoblasts to chemical inhibitors of PI3 kinase blocks myogenesis (Kaliman et al., 1996; Pinset et al., 1997) and constitutive activation of RhoA enhances myogenesis Takano et al., 1998; Meriane et al., 2000) . Therefore, the available experimental evidence has resulted in our embracing an alternative hypothesis ± that there is yet another pathway that mediates the eects of Ras in this model system. In this study, we have investigated the role of NFkB, another downstream Ras eector, in the inhibition of myogenesis. Our study was prompted by a number of reports describing the importance of NFkB activation to cellular transformation by Ras (Finco et al., 1997; Jo et al., 2000) , to progression through the G1 phase of cell cycle (Bargou et al., 1997; Grumont et al., 1998; Hinz et al., 1999) and to protecting cells from Rasinduced apoptosis (Mayo et al., 1997) . Guttridge et al. (1999) demonstrated that constitutive activation of NFkB blocks the dierentiation of muscle cells, presumably by up-regulating transcription of the cyclin D1 gene and preventing the DM-induced cell cycle arrest that is a critical prerequisite to myogenic dierentiation. These results supported earlier studies describing the non-myogenic phenotype of myoblasts overexpressing cyclin D1 (Rao et al., 1994; Zhang et al., 1999) . Our present work has extended these observations by showing that the forced expression of Ras G12V and the Ras eector-loop variants in 10T1/2-MyoD cells treated with DM results in the activation of endogenous NFkB transcriptional activity. Furthermore, our studies con®rm that constitutive activation of NFkB, either by expression of the RelA/p65 subunit or by treatment of the cultures with TNFa, blocks the biochemical and morphological dierentiation of 10T1/2-MyoD cells. However, while Ras G12V and each of the Ras variants lead to the activation of NFkB in DM, our results also show that only Ras G12V stimulates the accumulation of cyclin D1 protein and promotes a signi®cant level of cell cycle progression. DM-treated cells expressing the Ras eector variants arrest growth appropriately, yet maintain a dierentiation-defective Ras phenotype. The importance of NFkB activation to the phenotype of Ras G12V expressing cells was investigated by coexpressing IkBa SR. This protein completely reversed NFkB reporter gene expression stimulated by Ras, but did not restore expression of the muscle-speci®c reporter gene TnI-Luc or lead to any visible signs of morphological dierentiation in the cultures (Figure 6 ). This is in stark contrast to the dierentiation-defective phenotype of 10T1/2-MyoD cells expressing p65 or treated with TNFa. In both of these cases, myogenesis is completely restored following expression of IkBa SR ( Figure 6 and data not shown). We conclude from these experiments that activated Ras does not rely on the downstream activation of NFkB to block myogenesis and, interestingly, that the cellular consequences of NFkB activation by the Ras variants are qualitatively dierent from those induced by Ras G12V since they are not correlated with increased cyclin D1 accumulation or a failure to cell cycle arrest. Although we have not determined whether the lack of cyclin D1 accumulation with the variants is due to decreased cyclin D1 gene transcription or to increased cyclin D1 protein instability, we suspect the latter since our experiments with the NFkB reporter gene indicate that all Ras proteins stimulate the transactivation properties of NFkB appropriately. In this regard, Gille and Downward (1999) have demonstrated a synergy between individual Ras signaling pathways to activate cyclin D1 transcription, protein accumulation and protein activity during the G1 to S transition (Gille and Downward, 1999) . Experiments currently underway with a cyclin D1 reporter construct will directly address these possibilities.
With a role for NFkB in the inhibition of myogenesis by Ras ruled out, we next tested if activation of endogenous Ras p21 was an intermediate in the activation of NFkB by TNFa. By expressing the dominant-negative Ras N17 variant, which blocks full activation of MAP kinase by EGF in 10T1/2 cells (Figure 5a ), we show no eect on the inhibition of myogenesis by TNFa. Since signaling by TNFa in other cell types is associated with Ras activation (Trent et al., 1996; Anrather et al., 1999) , these results have revealed the existence of a TNFa-induced, Rasindependent mechanism through which NFkB can be activated to exert profound eects in cells. Interestingly, in a series of experiments designed to investigate the involvement of Ras activation in TNFa-induced cell growth and apoptosis in C3H10T1/2 ®broblasts, Trent et al. (1996) showed that TNFa treatment did not increase intracellular levels of GTP-bound Ras in this cell type. Our results would suggest that despite the inability to activate endogenous Ras p21, TNFa treatment of 10T1/2 cells still leads to NFkB activation.
We continue to be intrigued by the molecular mechanism of the Ras-induced inhibition of myogenesis, both by the identity of the components of the cytoplasmic signaling cascade activated by Ras in myoblasts and by the precise nuclear events initiated by this cascade that culminate in the inhibition of MyoD activity. Based on the data in this paper, we now have ruled out a signi®cant contribution from NFkB activation in this cascade and essentially any obligate role for continued cell cycle progression in the process. Clearly, the next step is to focus on qualitative dierences between myoblasts arrested in the cell cycle in the presence or absence of the Ras eector-loop variants. The status of Cdk inhibitors such as p21 and p27 should be examined since previous reports have demonstrated a role for p21 and p27 in promoting myogenesis (Halevy et al., 1995; Skapek et al., 1995; Wang and Walsh, 1996; Zabludo et al., 1998) . Similarly, the potential regulation of the p38 MAPK pathway by Ras and the Ras variants is attractive, given the recent report that p38-directed phosphorylation events enhance MyoD-induced myogenesis (Zetser et al., 1999; Wu et al., 2000) . In addition, we have initiated a library screen to identify novel Ras eectors in muscle cells. The complete delineation of the Ras signaling pathway(s) that prevents complete cell cycle withdrawal and terminal dierentiation, without inducing cell cycle progression, will impact our understanding of skeletal muscle dierentiation and may help to explain how early mutational activation of Ras proteins contributes to tumor initiation in vivo.
Materials and methods

Cell lines and media
C3H10T1/2 Clone 8 mouse embryo ®broblasts (10T1/2) were obtained from the American Type Culture Collection (ATCC CCL 226) and were maintained at subcon¯uent density in high glucose Dulbecco modi®ed Eagle medium (DMEM-H) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin (GIBCO ± BRL, Rockville, MD, USA). 10T1/2 MyoD-ER cells (Hollenberg et al., 1993) were maintained on gelatinized plates in DMEM-H, 10% calf serum (GIBCO ± BRL) and antibiotics. Myogenesis was induced by exposure to dierentiation medium (DM) consisting of DMEM-H, 2% horse serum and antibiotics. Where indicated, cultures were treated with medium supplemented with 0.1 mM b-estradiol (Sigma, St. Louis, MO, USA), 100 ng/ml EGF (Sigma) or 20 ng/ml TNFa (Sigma).
Plasmids pEMSV scribea2, pEM-MyoD, TnI-Luc, pGT5-Luc ((Gal4) 5 -Luc), Gal4-Elk and the pDCR vectors expressing Ras G12V and the T35S, E37G and Y40C Ras variants have been described previously (Kong et al., 1995; Ramocki et al., 1997) . pSVX RasN17 expressing dominant-negative Ras was obtained from S Green (University of Iowa). The 36kB-Luc reporter gene (Guttridge et al., 1999) and a plasmid expressing the RelA/p65 protein (Beg et al., 1992) were gifts of AS Baldwin (University of North Carolina). IkBa SR (Brockman et al., 1995) was obtained from D Ballard (Vanderbilt University).
Transfection
10T1/2 or 10T1/2-MyoD-ER cells were seeded in 6-well plates at 1610 5 cells per well in growth medium. On the following day, the cells were exposed to SuperFect Transfection Reagent as instructed by the manufacturer (Qiagen, Valencia, CA, USA) in 600 ml of growth medium containing the DNA amounts indicated in each Figure legend . After 3 h in SuperFect, the cells were rinsed in calcium and magnesium free (CMF)-saline (130 mM NaCl, 1.5 mM KH 2 PO 4 , 2.7 mM KCl, 8 mM Na 2 HPO 4 , 0.001% phenol red, pH 7.4) and the medium replaced by fresh growth medium for 24 h. To induce dierentiation, the cultures were rinsed twice in CMFsaline and the medium switched to DM (containing bestradiol or TNFa where indicated). After 24 h in DM, cell extracts were prepared and luciferase activities measured as described previously .
Immunofluorescence
10T1/2-MyoD-ER cells were plated in growth medium at a density of 2610 5 cells per gelatinized 60 mm dish. The following day, the cells were exposed to SuperFect reagent as described above using 1 ml of growth medium containing 2 mg of the indicated plasmid DNA. Twenty-four hours after removal of SuperFect, the cultures were treated with DM and b-estradiol for 48 h. Dierentiated cultures were washed twice in CMF-saline, ®xed with a solution of 4% formaldehyde in phosphate-buered saline (PBS; 140 mM NaCl, 1.8 mM KH 2 PO 4 , 2.7 mM KCl, 10 mM Na 2 HPO 4 , pH 7.4) and stored at 48C under PBS. Cells were permeabilized by incubating at 308C for 45 min in a solution of PBS containing 1% horse serum and 0.1% Triton X-100. To detect hemagglutinin antigen (HA)-tagged Ras proteins and cyclin D1, cells were incubated ®rst with 3 mg/ml anti-HA monoclonal antibody 12CA5 (Roche, Indianapolis, IN, USA) followed by 6.7 mg/ml¯uorescein conjugated rabbit anti-mouse IgG 2b (American Qualex, San Clemente, CA, USA) and then with 1.3 mg/ml anti-cyclin D1 monoclonal antibody 72-13G (Santa Cruz, Santa Cruz, CA, USA) followed by 5 mg/ml Texas Red conjugated rabbit anti-mouse IgG1 (American Qualex). To detect HA-Ras and troponin T, cultures were incubated as above with the anti-HA primary antibody and¯uorescein labeled secondary antibody and then with a 1 : 5 dilution of anti-troponin T monoclonal antibody CT3 (Developmental Studies Hybridoma Bank) followed by 5.7 mg/ml Texas Red conjugated rabbit antimouse IgG 2a (American Qualex). Incubations were performed overnight at 48C with each primary antibody and 75 min at room temperature with each secondary antibody. Cells were washed with PBS several times between treatments. Staining was visualized using an Olympus¯uorescence microscope and photographed under 4006for analysis.
Cell cycle analysis
To approximate the per cent of cycling cells, 10T1/2 cultures were plated, transfected, dierentiated and ®xed as described in previous sections, except that 10 mM 5-bromo-2'-deoxyuridine (BrdU; Roche) was added to the DM 18 h prior to ®xation. Fixed cells were incubated with 2 N HCl for 1 h at room temperature, washed with TBE (90 mM Tris-borate, 2 mM EDTA, pH 8.0) and permeabilized as described above. Cells expressing HA-Ras proteins were detected as described above and BrdU uptake assessed in the same cultures by incubation with a 1 : 100 dilution of anti-BrdU monoclonal antibody G3G4 (Developmental Studies Hybridoma Bank) and 5 mg/ml Texas Red conjugated secondary rabbit antimouse IgG1. Stained cells were visualized and photographed as described above.
Myofiber formation
The eciency of myo®ber formation in 10T1/2 cells transfected with MyoD was determined as described previously . Brie¯y, cells transfected with the amounts of plasmid DNA indicated in the Figure legend were exposed to DM for 48 h and ®xed in a solution of 70% ethanol-formalin-acetic acid (20 : 2 : 1). A 1 : 5 dilution of monoclonal antibody MF-20 (Developmental Studies Hybridoma Bank) was used to detect myosin heavy chain protein which was visualized with a biotinylated secondary antibody and Vectastain kit reagents (Vector Laboratories). Immunostained cultures were viewed under bright light conditions and ®bers scored and photographed at 1006mag-ni®cation. For each experimental group, the average number of myo®bers in ®ve randomly chosen microscope ®elds is expressed relative to the MyoD control group which is set at 100.
Western blot hybridization
Cell extracts from transfected 10T1/2 cells were prepared, resolved by SDS ± PAGE and transferred to nitrocellulose membrane as described previously . Blocking, hybridization and washes also were performed as described in Ramocki et al. (1997) . The HA monoclonal antibody 12CA5 was used to detect HA-Ras and the Flag M2 monoclonal antibody (Sigma) was used to detect FlagIkBa SR and Flag-p65 proteins. Immunoreactive complexes were visualized on the blot using peroxidase conjugated secondary antisera and enhanced chemiluminescent reagents purchased from Amersham.
